Analyst Ratings for MapLight Therapeutics (MPLT)
MPLT Rating Summary
MPLT Price Target Summary
- Highest: $52.00 (UBS)
- Lowest: $30.00 (Leerink)
- Average: $40.09
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$40.09 (+13.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/20/2026 | BMO Capital | Malcolm Hoffman | New Coverage | Outperform (N/A) |
46.00 (N/A) |
37.87 (35.31) |
-6.76% | Details |
| 6/24/2026 | Raymond James | Tiago Fauth | New Coverage | Strong Buy (N/A) |
46.00 (N/A) |
28.64 (35.31) |
23.29% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
